Myocardial Solutions is committed to helping people access MyoStrain through certified imaging centers such as the one found at Memorial MRI & Diagnostic.
Links to all outside sites do not imply a recommendation of a particular provider by Myocardial Solutions, nor an endorsement of MyoStrain by an imaging provider. Myocardial Solutions accepts no responsibility or liability for the content or services of other websites. All prescription decisions are made by the healthcare provider, based on the patient’s needs.
A clinical study showed MyoStrain was able to detect asymptomatic heart dysfunction in patients suspected of heart failure. This helped cardiologists to assess their risk early and monitor the effectiveness of their treatment over time.³
[1] Guisca S, et al. Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardial Strain, T1 and T2 Mapping, and Biochemical Markers: A Longitudinal Cardiac Resonance Imaging Study During 2 Years of Follow-Up. Circulation. 2021;14:e012459 [2] Steen, H., Giusca, S., Montenbruck M, et al. (2021). Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis. J Cardiovasc Magn Reson 23, 45. https://doi.org/10.1186/s12968-021-00711-w [3] Korosoglou G, et al. J Am Coll Cardiol Cardiovasc Imaging. Jan 13,2021. DOI: 10.1016/j.jcmg.2020.10.024. [4] University of Michigan Health. Heart Failure: Compensation by the Heart and Body. https://www.uofmhealth.org/health-library/aa86963 [5] Korosoglou G, et al. Strain-encoded Magnetic resonance: A Method for the Assessment of Myocardial Deformation. ESC Heart Failure. 2019: 1-19. doi:10.1002/ehf2.12442.